Ten years after the first etanercept copy reached European patients, the EMA, real-world registries and rheumatologists have ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine p ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher's AI Network Medicine ...

Ravichandran says Agnikul is targeting up to 50 launches a year by 2030, roughly one launch every week, enabled by reusable ...

Sri Lanka tried to make the play in the second Test, declaring at 9-549 after winning the toss and batting. West Indies saved ...

Saturday’s buffet of rugby served up a delicious treat for fans across the globe, but one alarming factor stood out that ...

Ashwin Critiques Sooryavanshi's Debut Timing Former Indian cricketer Ravichandran Ashwin has expressed his concerns regarding ...

Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...

Rheumatoid factor may be associated with more significant disease burden and less response to treatment in patients with PsA.

Acrivon Therapeutics trades below cash value, with the market deeply discounting its platform and pipeline despite promising ...

Trump administration officials say Tehran must hand over 'nuclear dust' or there won't be a deal, as satellite images show ...

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.